SCHEMBL20705772

SCHEMBL20705772

CCOc1cc2c(c3c1CNC3)C(=O)C=CC2=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.39
TSHR P16473 2/20 0.35
CYP3A4 P08684 1/20 0.35
CDC25A P30304 1/20 0.34
CDC25B P30305 1/20 0.34
CDC25C P30307 1/20 0.34
PDE4A P27815 3/20 0.33
ABCC4 O15439 1/20 0.33
ABCB11 O95342 1/20 0.33
CHRM2 P08172 1/20 0.33
ADRA2A P08913 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
CHRM1 P11229 1/20 0.33
PTGS1 P23219 1/20 0.33
SLC6A4 P31645 1/20 0.33
KCNH2 Q12809 1/20 0.33
PIM1 P11309 1/20 0.32
TOP1 P11387 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20705751 0.89 HTR6 (0.36) ACHECDC25ACDC25BCDC25CPDE4A
SCHEMBL1779822 0.67 TSHR (0.41) ACHETSHRCYP3A4TOP1PDE3A
SCHEMBL24194104 0.66 PIM1 (0.43) TSHRCYP3A4PIM1TOP1LMNA
SCHEMBL27854879 0.66 ACHE (0.44) ACHETSHRCYP3A4PDE4AABCC4
SCHEMBL30574283 0.65 TOP1 (0.66) CYP3A4CDC25BTOP1LMNAALDH1A1
SCHEMBL24194098 0.65 TOP1 (0.66) CYP3A4CDC25BTOP1LMNAALDH1A1
SCHEMBL15119582 0.61 ACHE (0.47) ACHETSHRCYP3A4CDC25BADORA3
SCHEMBL9839597 0.61 TSHR (0.47) ACHETSHRCYP3A4LMNAALDH1A1
SCHEMBL11491934 0.60 TSHR (0.58) ACHETSHRCYP3A4PDE4ALMNA
SCHEMBL19582577 0.59 ALDH1A1 (0.45) ACHETSHRCYP3A4PDE4APIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10197557-B2 Small molecules for endothelial cell activation THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10197557-B2 Small molecules for endothelial cell activation LIPG, VCAM1, SELE ACHE 4324/4885TSHR 4000/4885CYP3A4 4315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.